Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Whole-body prepulse inhibition protocol to test sensorymotor gating mechanisms in monkeys.Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia PharmacotherapyPostnatal Development of Subcallosal Zone Following Suppression of Programmed Cell Death in Bax-deficient Mice.Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strainHabituation and prepulse inhibition of acoustic startle in rodentsCannabinoid CB₂ receptor-mediated regulation of impulsive-like behaviour in DBA/2 miceMemory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptorsStartle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population.Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice.Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult ratsEffect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats.Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.Prunella vulgaris attenuates prepulse inhibition deficit and attention disruption induced by MK-801 in mice.Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice.Endocannabinoids and Schizophrenia.
P2860
Q24645703-627ACF9E-D3A5-49B1-B09A-FF20638ED91AQ27313960-E9F3084E-8F72-4C2F-9C3C-8EFE8FE09DC7Q28078534-C05680B9-80AF-47D2-A664-75A461AAAEC2Q30412613-04F66734-22E2-4DEA-B177-D838BE8AB30AQ30442731-FD9DF1EB-55A3-4F31-B9BF-024C3DAC9A00Q30450016-FCFC1E57-11EB-437D-A094-831D30BA0919Q30459482-080F0354-7DA6-4D6F-8777-31D9B3DB34EFQ30465050-DFE1F715-211F-45DA-BDB0-CD52837A3856Q30465425-19B6882B-DEE3-4162-875F-FF73324ADF7AQ30467877-423F8E76-153C-4C6A-AD59-46B316D720ABQ30475004-D739E990-B1C2-46A4-8C0B-B6B8EF5F6081Q30489165-3E6A830D-6A69-49E5-9833-BC40EB34BD80Q34103173-95578E6F-3472-46C2-8BB1-16B57BD0A347Q46370479-B7402064-4A89-4004-9D1B-CBB0AC45E0C6Q48194937-AF1EAE1D-AB8A-417C-BE2D-6328D61A4E85Q48262695-D304A8A5-3584-4327-A1A6-6A14AA5308D9Q48286778-DBB9C85C-B9B0-494D-972E-F713E05AD4BFQ50561525-DFA5FE84-6856-4ECA-B4C1-6EE448AB740DQ50652493-E46E1F9A-E7D2-4EF7-9059-6B6BDC8F897FQ52649152-08267B55-68DE-4FEC-AF2A-CFDA7EDE56EDQ55452539-556A8C14-279B-4802-9212-D14D0D8DE40A
P2860
Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Cannabinoid receptor antagonis ...... ncyclidine model of psychosis.
@en
Cannabinoid receptor antagonis ...... ncyclidine model of psychosis.
@nl
type
label
Cannabinoid receptor antagonis ...... ncyclidine model of psychosis.
@en
Cannabinoid receptor antagonis ...... ncyclidine model of psychosis.
@nl
prefLabel
Cannabinoid receptor antagonis ...... ncyclidine model of psychosis.
@en
Cannabinoid receptor antagonis ...... ncyclidine model of psychosis.
@nl
P2093
P2860
P50
P921
P356
P1476
Cannabinoid receptor antagonis ...... encyclidine model of psychosis
@en
P2093
Andreas Heinz
Cristina Rizzetti
GianLuigi Gessa
Martina Ballmaier
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301344
P407
P577
2007-02-14T00:00:00Z